Preview

Journal of Siberian Medical Sciences

Расширенный поиск

Application of Viprazan in physiopharmacotherapeutic techniques at treatment of patients with osteoarthritis of knee joints

Аннотация

We have examined 45 men and women at the age of 45 to 59 with osteoarthritis of the knee joints complained of a pain syndrome and limitation of motion in the lower extremities. All patients were divided into 3 groups: in the first group the basic medical treatment was supplemented with ultraphonophoresis of chitosan gel Viprazan with adder venom on the affected joints; in the second group it was carried out placebo procedure of ultraphonophoresis; in the third group the basic treatment was supplemented with application of Viprazan gel on painful zones during three weeks. Based on the research findings we have established that introduction by ultrasound of the gel Viprazan in circumarticular tissues promotes the decrease of indicators of the pain, constraint and functional insufficiency. According to WOMAC questionnaire the indicators of the pain, constraint and functional insufficiency were decreased 1.3 times, and total index - 1.2 times. Upon completion of a therapeutic course in patients of the first group it was noted the increase of degree of restoration of function of a joint up to 84.2% and an index of efficiency of microcirculation 2.1 times that was not observed in the placebo and comparison groups.

Об авторах

V. Drobyshev
Novosibirsk State Medical University
Россия


L. Shpagina
Novosibirsk State Medical University
Россия


O. Gerasimenko
Novosibirsk State Medical University
Россия


Z. Hayatova
Novosibirsk State Medical University
Россия


Список литературы

1. Naumov A.V., Shamuilova M.M. (2012). Osteoarthritis. Strategy of decisions: a look from height of modern knowledge. Сonsilium medicum, 14, 2, 81-85.

2. Bjordal J.M., Johnson, M.I. LopesMartins R.A. Bogen B., Chow R. Ljunggren A.E. (2007). Shortterm efficacy of physical interventions in osteoarthritic knee pain. A systematic review and metaanalysis of randomised placebocontrolled trials. BMC Musculoskelet. Disord., 8, 51.

3. Tuniyev B.S., Orlov N.L., Ananyeva N.B., Agasyan A.L. (2009). Zmei Kavkaza. Moscow: KMK. 223.

4. Orlov B.N., Valtseva I.A. (1987). Yady Zmei. Tashkent: Meditsina. 252.

5. Komarov B.A. (2005). Primenenie vodorastvorimyh form hitozana dlja lechenija i profilaktiki razlichnyh zabolevanij. Untraditional Natural Resources, Innovative Technologies and Products, 13, 190.

6. Bellamy N., Bushanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. (1988). Validation study of WOMAC: health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J. Rheumatol, 15, 1833-1840.

7. Belova A.N., Shchepetova O.N. ( Eds.) (2002). Shkaly, testy i oprosniki v medicinskoj reabilitacii. Moscow: Antidor. 407-411.


Рецензия

Для цитирования:


 ,  ,  ,   . Journal of Siberian Medical Sciences. 2017;(2):6-9.

For citation:


Drobyshev V.A., Shpagina L.A., Gerasimenko O.N., Hayatova Z.B. Application of Viprazan in physiopharmacotherapeutic techniques at treatment of patients with osteoarthritis of knee joints. Journal of Siberian Medical Sciences. 2017;(2):6-9.

Просмотров: 156


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2542-1174 (Print)